Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 3
1993 3
1994 1
1995 1
1996 1
1997 2
1999 1
2004 1
2009 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Screening for epidermal growth factor receptor mutations in lung cancer.
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M; Spanish Lung Cancer Group. Rosell R, et al. N Engl J Med. 2009 Sep 3;361(10):958-67. doi: 10.1056/NEJMoa0904554. Epub 2009 Aug 19. N Engl J Med. 2009. PMID: 19692684 Free article.
Phase II study of pegylated liposomal doxorubicin plus vinorelbine in breast cancer with previous anthracycline exposure.
Martin M, García-Donas J, Casado A, de la Gándara I, Pérez-Segura P, García-Saenz JA, Ibáñez G, Loboff B, García-Ledo G, Moreno F, Grande E, Diaz-Rubio E. Martin M, et al. Among authors: de la gandara i. Clin Breast Cancer. 2004 Dec;5(5):353-7. doi: 10.3816/cbc.2004.n.041. Clin Breast Cancer. 2004. PMID: 15585072 Clinical Trial.
Bone metastases as the first manifestation of a tumour.
Barón MG, de la Gándara I, Espinosa E, de Paredes ML, Zamora P, Mondéjar JL. Barón MG, et al. Among authors: de la gandara i. Int Orthop. 1991;15(4):373-6. doi: 10.1007/BF00186882. Int Orthop. 1991. PMID: 1725677
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
González Barón M, Feliu J, Espinosa E, García Girón C, Blanco E, Garrido P, Colmenarejo A, Ordóñez A, Moyano A, de la Gándara I, et al. González Barón M, et al. Among authors: de la gandara i. Ann Oncol. 1994 Apr;5(4):323-7. doi: 10.1093/oxfordjournals.annonc.a058834. Ann Oncol. 1994. PMID: 8075028 Free article. Clinical Trial.
Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group.
Feliu J, López Gómez L, Madroñal C, Espinosa E, Espinosa J, Girón CG, Martínez B, Castro J, De la Gándara I, Barón MG. Feliu J, et al. Among authors: de la gandara i. Cancer. 1999 Oct 15;86(8):1463-9. doi: 10.1002/(sici)1097-0142(19991015)86:8<1463::aid-cncr12>3.0.co;2-n. Cancer. 1999. PMID: 10526274 Clinical Trial.
[A critique of euthanasia].
Espinosa E, González Barón M, de la Gándara I. Espinosa E, et al. Among authors: de la gandara i. Rev Clin Esp. 1993 Mar;192(5):231-2. Rev Clin Esp. 1993. PMID: 7683439 Spanish. No abstract available.
15 results